• Explore /
  • Poster
  • / <span>Preliminary antitumor activity of COM701 in combination with COM902 and pembrolizumab in patients with MSS-CRC and liver metastases.</span>

Preliminary antitumor activity of COM701 in combination with COM902 and pembrolizumab in patients with MSS-CRC and liver metastases.

Abstract Poster

Authors

null

Manish Sharma

START Midwest, Grand Rapids, MI

Manish Sharma , Anne M. Noonan , Daniel A. Vaena , Ecaterina Elena Dumbrava , Judy S. Wang , Drew W. Rasco , Kyriakos P. Papadopoulos , Aditya V. Shreenivas , Pierre Ferre , Eran Ophir , Inbal Barbiro , Gady Cojocaru , Michelle Mahler , Adeboye H. Adewoye , Manish R. Patel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT04354246.

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 3597)

DOI

10.1200/JCO.2024.42.16_suppl.3597

Abstract #

3597

Poster Bd #

260

Abstract Disclosures

Similar Posters

First Author: Drew W. Rasco

First Author: Lorenzo Pilla

First Author: Shipra Gandhi

First Author: Karim Amrane Sr.